{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:40:35Z","timestamp":1792723235743,"version":"4.5.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,12]],"date-time":"2011-02-12T00:00:00Z","timestamp":1297468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s13277-011-0155-8","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T04:31:45Z","timestamp":1297398705000},"page":"425-440","source":"Crossref","is-referenced-by-count":122,"title":["Cancer stem cells and cancer therapy"],"prefix":"10.1007","volume":"32","author":[{"given":"Sara","family":"Soltanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam M.","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,12]]},"reference":[{"key":"155_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer and cancer stem cells. Nature. 2001;414:105\u201311.","journal-title":"Nature"},{"key":"155_CR2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(02)00820-3","volume":"3","author":"SM Tu","year":"2002","unstructured":"Tu SM, Lin SH, Logothetis CJ. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol. 2002;3:508\u201313.","journal-title":"Lancet Oncol"},{"key":"155_CR3","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1073\/pnas.2034201100","volume":"100","author":"E Passegue","year":"2003","unstructured":"Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics. Proc Natl Acad Sci USA. 2003;100:11842\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","volume":"23","author":"NA Lobo","year":"2007","unstructured":"Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23:675\u201399.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"155_CR5","first-page":"23","volume":"8","author":"R Virchow","year":"1855","unstructured":"Virchow R. Editorial. Arch Pathol Anat Physiol Klin Med. 1855;8:23.","journal-title":"Arch Pathol Anat Physiol Klin Med"},{"key":"155_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2004.04.007","volume":"51","author":"S Sell","year":"2004","unstructured":"Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol. 2004;51:1\u201328.","journal-title":"Crit Rev Oncol Hematol"},{"key":"155_CR7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645\u20138.","journal-title":"Nature"},{"key":"155_CR8","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumourigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396\u2013401.","journal-title":"Nature"},{"key":"155_CR10","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2004-07-2514","volume":"105","author":"B Fang","year":"2005","unstructured":"Fang B, Zheng C, Liao L, Han Q, Sun Z, Jiang X, et al. Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood. 2005;105:2733\u201340.","journal-title":"Blood"},{"key":"155_CR11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67:1030\u20137.","journal-title":"Cancer Res"},{"key":"155_CR12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"ME Prince","year":"2007","unstructured":"Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007;104:973\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","volume":"451","author":"T Schatton","year":"2008","unstructured":"Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, et al. Identification of cells initiating human melanomas. Nature. 2008;451:345\u20139.","journal-title":"Nature"},{"key":"155_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2008.01.013","volume":"13","author":"ZF Yang","year":"2008","unstructured":"Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008;13:153\u201366.","journal-title":"Cancer Cell"},{"key":"155_CR15","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1158\/0008-5472.CAN-08-2242","volume":"69","author":"ML Suv\u00e0","year":"2009","unstructured":"Suv\u00e0 ML, Riggi N, Stehle JC, Baumer K, Tercier S, Joseph JM, et al. Identification of cancer stem cells in Ewing's sarcoma. Cancer Res. 2009;69:1776\u201381.","journal-title":"Cancer Res"},{"key":"155_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nature09161","volume":"466","author":"AD Boiko","year":"2010","unstructured":"Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature. 2010;466:133\u20137.","journal-title":"Nature"},{"key":"155_CR17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jnci\/djp535","volume":"102","author":"ZA Rasheed","year":"2010","unstructured":"Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, et al. Prognostic significance of tumourigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst. 2010;102:340\u201351.","journal-title":"J Natl Cancer Inst"},{"key":"155_CR18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1142596","volume":"317","author":"PN Kelly","year":"2007","unstructured":"Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. Tumour growth need not be driven by rare cancer stem cells. Science. 2007;317:337.","journal-title":"Science"},{"key":"155_CR19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","volume":"456","author":"E Quintana","year":"2008","unstructured":"Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature. 2008;456:593\u20138.","journal-title":"Nature"},{"key":"155_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.stem.2010.08.009","volume":"7","author":"K Ishizawa","year":"2010","unstructured":"Ishizawa K, Rasheed ZA, Karisch R, Wang Q, Kowalski J, Susky E, et al. Tumour initiating cells are rare in many human tomour. Cell Stem Cell. 2010;7:279\u201382.","journal-title":"Cell Stem Cell"},{"key":"155_CR21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u20137.","journal-title":"Nat Med"},{"key":"155_CR22","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumours. Cancer Res. 2003;63:5821\u20138.","journal-title":"Cancer Res"},{"key":"155_CR23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","volume":"121","author":"CF Kim","year":"2005","unstructured":"Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005;121:823\u201335.","journal-title":"Cell"},{"key":"155_CR24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","volume":"25","author":"L Patrawala","year":"2006","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumours are enriched in tumourigenic and metastatic progenitor cells. Oncogene. 2006;25:1696\u2013708.","journal-title":"Oncogene"},{"key":"155_CR25","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","volume":"65","author":"AT Collins","year":"2005","unstructured":"Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumourigenic prostate cancer stem cells. Cancer Res. 2005;65:10946\u201351.","journal-title":"Cancer Res"},{"key":"155_CR26","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","volume":"103","author":"PP Szotek","year":"2006","unstructured":"Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA. 2006;103:11154\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O\u2019Brien","year":"2007","unstructured":"O\u2019Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106\u201310.","journal-title":"Nature"},{"key":"155_CR28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon cancer-initiating cells. Nature. 2007;445:111\u20135.","journal-title":"Nature"},{"key":"155_CR29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)00050-7","volume":"102","author":"G Taylor","year":"2000","unstructured":"Taylor G, Lehrer MS, Jensen PJ, Sun TT, Lavker RM. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell. 2000;102:451\u201361.","journal-title":"Cell"},{"key":"155_CR30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2004.08.012","volume":"118","author":"C Blanpain","year":"2004","unstructured":"Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118:635\u201348.","journal-title":"Cell"},{"key":"155_CR31","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1042\/BST20051526","volume":"33","author":"PW Andrews","year":"2005","unstructured":"Andrews PW, Matin M, Bahrami AR, Damjanov I, Gokhale P, Draper JS. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans. 2005;33:1526\u201330.","journal-title":"Biochem Soc Trans"},{"key":"155_CR32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nrc1232","volume":"3","author":"R Pardal","year":"2003","unstructured":"Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3:895\u2013902.","journal-title":"Nat Rev Cancer"},{"key":"155_CR33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003;423:255\u201360.","journal-title":"Nature"},{"key":"155_CR34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature03100","volume":"432","author":"PA Beachy","year":"2004","unstructured":"Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432:324\u201331.","journal-title":"Nature"},{"key":"155_CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gde.2003.11.007","volume":"14","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Berker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004;14:43\u20137.","journal-title":"Curr Opin Genet Dev"},{"key":"155_CR36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275\u201383.","journal-title":"Nat Rev Cancer"},{"key":"155_CR37","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1349-7006.2008.00914.x","volume":"99","author":"H Ishii","year":"2008","unstructured":"Ishii H, Iwatsuki M, Ieta K, Ohta D, Haraguchi N, Mimori K, et al. Cancer stem cells and chemoradiation resistance. Cancer Sci. 2008;99:1871\u20137.","journal-title":"Cancer Sci"},{"key":"155_CR38","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1182\/blood.V88.6.1944.bloodjournal8861944","volume":"88","author":"W Terpstra","year":"1996","unstructured":"Terpstra W, Ploemacher RE, Prins A, van Lom K, Pouwels K, Wognum AW, et al. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood. 1996;88:1944\u201350.","journal-title":"Blood"},{"key":"155_CR39","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.onc.1205075","volume":"21","author":"JH Ohyashiki","year":"2002","unstructured":"Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K. Telomeres and telomerase in hematologic neoplasia. Oncogene. 2002;21:680\u20137.","journal-title":"Oncogene"},{"key":"155_CR40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000092502","volume":"1","author":"Z Ju","year":"2006","unstructured":"Ju Z, Rudolph KL. Telomeres and telomerase in stem cells during aging and disease. Genome Dyn. 2006;1:84\u2013103.","journal-title":"Genome Dyn"},{"key":"155_CR41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/345686a0","volume":"345","author":"MH Rosner","year":"1990","unstructured":"Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature. 1990;345:686\u201392.","journal-title":"Nature"},{"key":"155_CR42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0962-8924(02)02352-8","volume":"12","author":"T Burdon","year":"2002","unstructured":"Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 2002;12:432\u20138.","journal-title":"Trends Cell Biol"},{"key":"155_CR43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrm1744","volume":"6","author":"M Boiani","year":"2005","unstructured":"Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 2005;6:872\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"155_CR44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1634\/stemcells.22-5-659","volume":"22","author":"MM Matin","year":"2004","unstructured":"Matin MM, Walsh JR, Gokhale PJ, Draper JS, Bahrami AR, Morton I, et al. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells. 2004;22:659\u201368.","journal-title":"Stem Cells"},{"key":"155_CR45","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","volume":"65","author":"D Ponti","year":"2005","unstructured":"Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumourigenic breast cancer cells with stem\/progenitor cell properties. Cancer Res. 2005;65:5506\u201311.","journal-title":"Cancer Res"},{"key":"155_CR46","doi-asserted-by":"crossref","first-page":"e2637","DOI":"10.1371\/journal.pone.0002637","volume":"3","author":"YC Chen","year":"2008","unstructured":"Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133+ cells. PLoS One. 2008;3:e2637.","journal-title":"PLoS One"},{"key":"155_CR47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbrc.2009.02.156","volume":"383","author":"M Schoenhals","year":"2009","unstructured":"Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B. Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun. 2009;383:157\u201362.","journal-title":"Biochem Biophys Res Commun"},{"key":"155_CR48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48\u201350.","journal-title":"Nat Rev Cancer"},{"key":"155_CR49","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","volume":"7","author":"S Zhou","year":"2001","unstructured":"Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, et al. The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7:1028\u201334.","journal-title":"Nat Med"},{"key":"155_CR50","first-page":"497","volume":"88","author":"A Stijn Van","year":"2003","unstructured":"Van Stijn A, Van der Pol MA, Kok A, Bontje PM, Roemen GM, Beelen RH, et al. Differences between the CD34+ and CD34\u2212 blast compartments in apoptosis resistance in acute myeloid leukemia. Haematologica. 2003;88:497\u2013508.","journal-title":"Haematologica"},{"key":"155_CR51","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756\u201360.","journal-title":"Nature"},{"key":"155_CR52","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458:780\u20133.","journal-title":"Nature"},{"key":"155_CR53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6604510","volume":"99","author":"S Raguz","year":"2008","unstructured":"Raguz S, Yague E. Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer. 2008;99:387\u201391.","journal-title":"Br J Cancer"},{"key":"155_CR54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)81691-8","volume":"100","author":"E Fuchs","year":"2000","unstructured":"Fuchs E, Segre JA. Stem cells: a new lease on life. Cell. 2000;100:143\u201355.","journal-title":"Cell"},{"key":"155_CR55","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.168.2.635","volume":"168","author":"SJ Morrison","year":"2002","unstructured":"Morrison SJ, Qian D, Jerebek L, Thiel BA, Park IK, Ford PS, et al. A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J Immunol. 2002;168:635\u201342.","journal-title":"J Immunol"},{"key":"155_CR56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.semcancer.2010.04.002","volume":"20","author":"M Shackleton","year":"2010","unstructured":"Shackleton M. Normal stem cells and cancer stem cells: similar and different. Semin Cancer Biol. 2010;20:85\u201392.","journal-title":"Semin Cancer Biol"},{"key":"155_CR57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","volume":"423","author":"T Reya","year":"2003","unstructured":"Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003;423:409\u201314.","journal-title":"Nature"},{"key":"155_CR58","first-page":"113","volume":"9","author":"AG Knudson Jr","year":"1973","unstructured":"Knudson Jr AG, Strong LC, Anderson DE. Heredity and cancer in man. Prog Med Genet. 1973;9:113\u201358.","journal-title":"Prog Med Genet"},{"key":"155_CR59","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1073\/pnas.1633833100","volume":"100","author":"S Jaiswal","year":"2003","unstructured":"Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, Weissman IL. Expression of BCR\/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemia. Proc Natl Acad Sci USA. 2003;100:10002\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR60","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1634\/stemcells.2006-0585","volume":"25","author":"A Shiras","year":"2007","unstructured":"Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR, Shastry P. Spontaneous transformation of human adult nontumourigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells. 2007;25:1478\u201389.","journal-title":"Stem Cells"},{"key":"155_CR61","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.stem.2010.07.010","volume":"7","author":"G Molyneux","year":"2010","unstructured":"Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R, et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell. 2010;7:403\u201317.","journal-title":"Cell Stem Cell"},{"key":"155_CR62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccr.2010.10.033","volume":"18","author":"AI Persson","year":"2010","unstructured":"Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, et al. Non-stem cell origin for oligodendroglioma. Cancer Cell. 2010;18:669\u201382.","journal-title":"Cancer Cell"},{"key":"155_CR63","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1101\/gad.1143403","volume":"17","author":"A Cozzio","year":"2003","unstructured":"Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. Similar MLL-ssociated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003;17:3029\u201335.","journal-title":"Genes Dev"},{"key":"155_CR64","first-page":"6","volume":"70","author":"S Sell","year":"1994","unstructured":"Sell S, Pierce G. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994;70:6\u201322.","journal-title":"Lab Invest"},{"key":"155_CR65","first-page":"175","volume":"43","author":"MZ Ratajczak","year":"2005","unstructured":"Ratajczak MZ. Cancer stem cells-normal stem cells \"Jedi\" that went over to the \"dark side\". Folia Histochem Cytobiol. 2005;43:175\u201381.","journal-title":"Folia Histochem Cytobiol"},{"key":"155_CR66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2008.04.008","volume":"119","author":"RC Zhao","year":"2008","unstructured":"Zhao RC, Zhu Y, Shi Y. New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells. Pharmacol Ther. 2008;119:74\u201382.","journal-title":"Pharmacol Ther"},{"key":"155_CR67","first-page":"9","volume":"12","author":"DA Spandidos","year":"2007","unstructured":"Spandidos DA. Oncogenes and tumour suppressor genes as paradigms in oncogenesis. J BUON. 2007;12:S9\u201312.","journal-title":"J BUON"},{"key":"155_CR68","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature04703","volume":"441","author":"OH Yilmaz","year":"2006","unstructured":"Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 2006;441:475\u201382.","journal-title":"Nature"},{"key":"155_CR69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng1928","volume":"39","author":"XC He","year":"2007","unstructured":"He XC, Yin T, Grindley JC, Tian Q, Sato T, Tao WA, et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet. 2007;39:189\u201398.","journal-title":"Nat Genet"},{"key":"155_CR70","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01587","volume":"423","author":"IK Park","year":"2003","unstructured":"Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003;423:302\u20135.","journal-title":"Nature"},{"key":"155_CR71","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1101\/gad.1299505","volume":"19","author":"AV Molofsky","year":"2005","unstructured":"Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 2005;19:1432\u20137.","journal-title":"Genes Dev"},{"key":"155_CR72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03195612","volume":"49","author":"J Gil","year":"2008","unstructured":"Gil J, Stembalska A, Pesz KA, Sasiadek MM. Cancer stem cells: the theory and perspectives in cancer therapy. J Appl Genet. 2008;49:193\u20139.","journal-title":"J Appl Genet"},{"key":"155_CR73","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ceb.2004.08.006","volume":"16","author":"M Kl\u00e9ber","year":"2004","unstructured":"Kl\u00e9ber M, Sommer L. Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol. 2004;16:681\u20137.","journal-title":"Curr Opin Cell Biol"},{"key":"155_CR74","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","volume":"14","author":"T Reya","year":"2005","unstructured":"Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;14:843\u201350.","journal-title":"Nature"},{"key":"155_CR75","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature06835","volume":"452","author":"I Malanchi","year":"2008","unstructured":"Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signaling. Nature. 2008;452:650\u20133.","journal-title":"Nature"},{"key":"155_CR76","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2010.10.032","volume":"18","author":"J Yeung","year":"2010","unstructured":"Yeung J, Esposito MT, Gandillet A, Zeisig BB, Griessinger E, Bonnet D, et al. \u03b2-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell. 2010;18:606\u201318.","journal-title":"Cancer Cell"},{"key":"155_CR77","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2001","unstructured":"Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001;15:3059\u201387.","journal-title":"Genes Dev"},{"issue":"10","key":"155_CR78","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1074\/jbc.275.15.10995","volume":"275","author":"RB Pepinsky","year":"2000","unstructured":"Pepinsky RB, Rayhorn P, Day ES, Dergay A, Williams KP, Galdes A, et al. Mapping sonic hedgehog\u2013receptor interactions by steric interference. J Biol Chem. 2000;275(10):10995\u20131001.","journal-title":"J Biol Chem"},{"key":"155_CR79","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0960-9822(99)80018-9","volume":"9","author":"M Murone","year":"1999","unstructured":"Murone M, Rosenthal A, de Sauvage FJ. Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr Biol. 1999;9:76\u201384.","journal-title":"Curr Biol"},{"key":"155_CR80","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nature04117","volume":"437","author":"KC Corbit","year":"2005","unstructured":"Corbit KC, Aanstad P, Singla V, Norman AR, Stainier DY, Reiter JF. Vertebrate Smoothened functions at the primary cilium. Nature. 2005;437:1018\u201321.","journal-title":"Nature"},{"key":"155_CR81","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nrc1229","volume":"3","author":"M Pasca di Magliano","year":"2003","unstructured":"Pasca di Magliano M, Hebrok M. Hedgehog signaling in cancer formation and maintenance. Nat Rev Cancer. 2003;3:903\u201311.","journal-title":"Nat Rev Cancer"},{"key":"155_CR82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12094-009-0341-y","volume":"11","author":"V Medina","year":"2009","unstructured":"Medina V, Calvo MB, D\u00edaz-Prado S, Espada J. Hedgehog signalling as a target in cancer stem cells. Clin Transl Oncol. 2009;11:199\u2013207.","journal-title":"Clin Transl Oncol"},{"key":"155_CR83","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.284.5415.770","volume":"284","author":"S Artavanis-Tsakonas","year":"1999","unstructured":"Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284:770\u20136.","journal-title":"Science"},{"key":"155_CR84","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm2009","volume":"7","author":"S Bray","year":"2006","unstructured":"Bray S. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006;7:678\u201389.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"155_CR85","first-page":"247","volume":"30","author":"M Katoh","year":"2007","unstructured":"Katoh M, Katoh M. Notch signaling in gastrointestinal tract. Int J Oncol. 2007;30:247\u201351.","journal-title":"Int J Oncol"},{"key":"155_CR86","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1634\/stemcells.2007-0368","volume":"26","author":"V Fox","year":"2008","unstructured":"Fox V, Gokhale PJ, Walsh JR, Matin M, Jones M, Andrews PW. Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation. Stem Cells. 2008;26:715\u201323.","journal-title":"Stem Cells"},{"key":"155_CR87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35077219","volume":"411","author":"J Taipale","year":"2001","unstructured":"Taipale J, Beachy PA. The Hedgehog and Wnt signalling pathways in cancer. Nature. 2001;411:349\u201354.","journal-title":"Nature"},{"key":"155_CR88","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nrc1186","volume":"3","author":"F Radtke","year":"2003","unstructured":"Radtke F, Raj K. The role of Notch in tumourigenesis: oncogene or tumour suppressor? Nat Rev Cancer. 2003;3:756\u201367.","journal-title":"Nat Rev Cancer"},{"key":"155_CR89","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1371\/journal.pone.0000576","volume":"2","author":"JL Boulay","year":"2007","unstructured":"Boulay JL, Miserez AR, Zweifel C, Sivasankaran B, Kana V, Ghaffari A, et al. Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumours. PLoS One. 2007;2:e576.","journal-title":"PLoS One"},{"key":"155_CR90","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1349-7006.2009.01130.x","volume":"100","author":"SY Lee","year":"2009","unstructured":"Lee SY, Kumano K, Nakazaki K, Sanada M, Matsumoto A, Yamamoto G, et al. Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma. Cancer Sci. 2009;100:920\u20136.","journal-title":"Cancer Sci"},{"key":"155_CR91","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1741-7015-8-72","volume":"8","author":"MM Lino","year":"2010","unstructured":"Lino MM, Merlo A, Boulay JL. Notch signaling in glioblastoma: a developmental drug target? BMC Med. 2010;8:72.","journal-title":"BMC Med"},{"key":"155_CR92","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.2898810","volume":"241","author":"GJ Spangrude","year":"1988","unstructured":"Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241:58\u201362.","journal-title":"Science"},{"key":"155_CR93","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1073\/pnas.94.10.5320","volume":"94","author":"M Bhatia","year":"1997","unstructured":"Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA. 1997;94:5320\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR94","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.012336799","volume":"99","author":"CJ Hogan","year":"2002","unstructured":"Hogan CJ, Shpall EJ, Keller G. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD\/SCID mice. Proc Natl Acad Sci USA. 2002;99:413\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR95","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1634\/stemcells.2006-0727","volume":"25","author":"T Kimura","year":"2007","unstructured":"Kimura T, Asada R, Wang J, Kimura T, Morioka M, Matsui K. Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells. 2007;25:1348\u201355.","journal-title":"Stem Cells"},{"key":"155_CR96","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/leu.2009.206","volume":"24","author":"T Kitamura","year":"2010","unstructured":"Kitamura T, Matsuoka Y, Kimura T, Takahashi M, Nakamoto T, Yosuda K, et al. In vivo dynamic of human cord-blood derived CD34\u2212SCID-repopulating cells using intra-bone marrow injection. Leukemia. 2010;24:162\u20138.","journal-title":"Leukemia"},{"key":"155_CR97","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2007-10-118331","volume":"112","author":"DC Taussig","year":"2008","unstructured":"Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 2008;112:568\u201375.","journal-title":"Blood"},{"key":"155_CR98","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2009-02-206565","volume":"115","author":"DC Taussig","year":"2010","unstructured":"Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T, et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(\u2212) fraction. Blood. 2010;115:1976\u201384.","journal-title":"Blood"},{"key":"155_CR99","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/bies.200900058","volume":"31","author":"T Schatton","year":"2009","unstructured":"Schatton T, Frank NY, Frank MH. Identification and targeting of cancer stem cells. Bioessays. 2009;31:1038\u201349.","journal-title":"Bioessays"},{"key":"155_CR100","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1053\/j.gastro.2007.04.025","volume":"132","author":"S Ma","year":"2007","unstructured":"Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumourigenic liver cancer stem\/progenitor cells. Gastroenterology. 2007;132:2542\u201356.","journal-title":"Gastroenterology"},{"key":"155_CR101","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","volume":"15","author":"A Eramo","year":"2008","unstructured":"Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumourigenic lung cancer stem cell population. Cell Death Differ. 2008;15:504\u201314.","journal-title":"Cell Death Differ"},{"key":"155_CR102","author":"F Cui","year":"2010","unstructured":"Cui F, Wang J, Chen D, Chen YJ. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer. Oncol Rep. 2010. doi: 10.3892\/or.2010.1115 .","journal-title":"Oncol Rep"},{"key":"155_CR103","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/ijc.24061","volume":"124","author":"P Chu","year":"2009","unstructured":"Chu P, Clanton DJ, Snipas TS, Lee J, Mitchell E, Nguyen M-L, et al. Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer. 2009;124:1312\u201321.","journal-title":"Int J Cancer"},{"key":"155_CR104","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1007\/s00018-010-0420-9","volume":"67","author":"MF Shi","year":"2010","unstructured":"Shi MF, Jiao J, Lu WG, Ye F, Ma D, Dong QG, et al. Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. Cell Mol Life Sci. 2010;67:3915\u201325.","journal-title":"Cell Mol Life Sci"},{"key":"155_CR105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2008.374","volume":"28","author":"T Baba","year":"2009","unstructured":"Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, et al. Epigenetic regulation of CD133 and tumourigenicity of CD133C ovarian cancer cells. Oncogene. 2009;28:209\u201318.","journal-title":"Oncogene"},{"key":"155_CR106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2184.36.s.1.6.x","volume":"36","author":"G Dontu","year":"2003","unstructured":"Dontu G, Al-Hajj M, Abdullah W, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003;36:59\u201372.","journal-title":"Cell Prolif"},{"key":"155_CR107","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1:555\u201367.","journal-title":"Cell Stem Cell"},{"key":"155_CR108","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1158\/0008-5472.CAN-08-4418","volume":"69","author":"EH Huang","year":"2009","unstructured":"Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumourigenesis. Cancer Res. 2009;69:3382\u20139.","journal-title":"Cancer Res"},{"key":"155_CR109","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1158\/1055-9965.EPI-09-0865","volume":"19","author":"Y Su","year":"2010","unstructured":"Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, et al. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumour-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:327\u201337.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"155_CR110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1757-2215-3-28","volume":"3","author":"K Penumatsa","year":"2010","unstructured":"Penumatsa K, Edassery SL, Barua A, Bradaric MJ, Luborsky JL. Differential expression of aldehyde dehydrogenase 1A1 (ALDH1) in normal ovary and serous ovarian tumours. J Ovarian Res. 2010;3:28.","journal-title":"J Ovarian Res"},{"key":"155_CR111","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-06-4180","volume":"67","author":"D Beier","year":"2007","unstructured":"Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133(+) and CD133(\u2212) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007;67:4010\u20135.","journal-title":"Cancer Res"},{"key":"155_CR112","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/labinvest.2008.57","volume":"88","author":"KM Joo","year":"2008","unstructured":"Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest. 2008;88:808\u201315.","journal-title":"Lab Invest"},{"key":"155_CR113","first-page":"2111","volume":"118","author":"SV Shmelkov","year":"2008","unstructured":"Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133 metastatic colon cancer cells initiate tumours. J Clin Invest. 2008;118:2111\u201320.","journal-title":"J Clin Invest"},{"key":"155_CR114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gde.2008.01.017","volume":"18","author":"RW Cho","year":"2008","unstructured":"Cho RW, Clarke MF. Recent advances in cancer stem cells. Curr Opin Genet Dev. 2008;18:48\u201353.","journal-title":"Curr Opin Genet Dev"},{"key":"155_CR115","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/labinvest.3700488","volume":"86","author":"BT Tan","year":"2006","unstructured":"Tan BT, Park CY, Ailles LE, Weissman IL. The cancer stem cell hypothesis: a work in progress. Lab Invest. 2006;86:1203\u20137.","journal-title":"Lab Invest"},{"key":"155_CR116","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1158\/0008-5472.CAN-03-3884","volume":"64","author":"Y Huang","year":"2004","unstructured":"Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, et al. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 2004;64:4294\u2013301.","journal-title":"Cancer Res"},{"key":"155_CR117","first-page":"632","volume":"13","author":"A Elliott","year":"2010","unstructured":"Elliott A, Adams J, Al-Hajj M. The ABCs of cancer stem cell drug resistance. IDrugs. 2010;13:632\u20135.","journal-title":"IDrugs"},{"key":"155_CR118","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00001622-200009000-00011","volume":"12","author":"B Tan","year":"2000","unstructured":"Tan B, Piwnica-Worms D, Ratner L. Multidrug resistance transporters and modulation. Curr Opin Oncol. 2000;12:450\u20138.","journal-title":"Curr Opin Oncol"},{"key":"155_CR119","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3171\/2010.2.JNS091607","volume":"113","author":"K Tamura","year":"2010","unstructured":"Tamura K, Aoyagi M, Wakimoto H, Ando N, Nariai T, Yamamoto M, et al. Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation. J Neurosurg. 2010;113:310\u20138.","journal-title":"J Neurosurg"},{"key":"155_CR120","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1523\/JNEUROSCI.1634-10.2010","volume":"30","author":"S Facchino","year":"2010","unstructured":"Facchino S, Abdouh M, Chatoo W, Bernier G. BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci. 2010;30:10096\u2013111.","journal-title":"J Neurosci"},{"key":"155_CR121","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","volume":"73","author":"A Sancar","year":"2004","unstructured":"Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39\u201385.","journal-title":"Annu Rev Biochem"},{"key":"155_CR122","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/1541-7786.MCR-08-0409","volume":"7","author":"M Ropolo","year":"2009","unstructured":"Ropolo M, Daga A, Griffero F, Foresta M, Casartelli G, Zunino A, et al. Comparative analysis of DNA repair in stem and nonstem glioma cell cultures. Mol Cancer Res. 2009;7:383\u201392.","journal-title":"Mol Cancer Res"},{"key":"155_CR123","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature07618","volume":"457","author":"A Viale","year":"2009","unstructured":"Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, et al. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature. 2009;457:51\u20136.","journal-title":"Nature"},{"key":"155_CR124","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/35044005","volume":"408","author":"BB Zhou","year":"2000","unstructured":"Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000;408:433\u20139.","journal-title":"Nature"},{"key":"155_CR125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8:579\u201391.","journal-title":"Nat Rev Drug Discov"},{"key":"155_CR126","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12282-009-0176-y","volume":"17","author":"K Kai","year":"2010","unstructured":"Kai K, Arima Y, Kamiya T, Saya H. Breast cancer stem cells. Breast Cancer. 2010;17:80\u20135.","journal-title":"Breast Cancer"},{"key":"155_CR127","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/annonc\/mdl074","volume":"17","author":"C Massard","year":"2006","unstructured":"Massard C, Deutsch E, Soria JC. Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol. 2006;17:1620\u20134.","journal-title":"Ann Oncol"},{"key":"155_CR128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12015-008-9037-x","volume":"4","author":"P Rajan","year":"2008","unstructured":"Rajan P, Srinivasan R. Targeting cancer stem cells in cancer prevention and therapy. Stem Cell Rev. 2008;4:211\u20136.","journal-title":"Stem Cell Rev"},{"key":"155_CR129","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/cdd.2008.20","volume":"15","author":"L Vermeulen","year":"2008","unstructured":"Vermeulen L, Sprick MR, Kemper K, Stassi G, Medema JP. Cancer stem cells\u2014old concepts, new insights. Cell Death Differ. 2008;15:947\u201358.","journal-title":"Cell Death Differ"},{"key":"155_CR130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1471-4892(03)00081-X","volume":"3","author":"AI Spira","year":"2003","unstructured":"Spira AI, Carducci MA. Differentiation therapy. Curr Opin Pharmacol. 2003;3:338\u201343.","journal-title":"Curr Opin Pharmacol"},{"key":"155_CR131","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1158\/1078-0432.CCR-09-1800","volume":"16","author":"B Campos","year":"2010","unstructured":"Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, et al. Differentiation therapy exerts antitumour effects on stem-like glioma cells. Clin Cancer Res. 2010;16:2715\u201328.","journal-title":"Clin Cancer Res"},{"key":"155_CR132","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/sj.leu.2403031","volume":"17","author":"R Ohno","year":"2003","unstructured":"Ohno R, Asou N, Ohnishi K. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia. 2003;17:1454\u201363.","journal-title":"Leukemia"},{"key":"155_CR133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008488","volume":"6","author":"N Clarke","year":"2004","unstructured":"Clarke N, Germain P, Altucci L, Gronemeyer H. Retinoids: potential in cancer prevention and therapy. Expert Rev Mol Med. 2004;6:1\u201323.","journal-title":"Expert Rev Mol Med"},{"key":"155_CR134","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/sj.embor.7400441","volume":"6","author":"A Taddei","year":"2005","unstructured":"Taddei A, Roche D, Bickmore WA, Almouzni G. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? EMBO Rep. 2005;6:520\u20134.","journal-title":"EMBO Rep"},{"key":"155_CR135","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1073\/pnas.182372299","volume":"99","author":"LM Butler","year":"2002","unstructured":"Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA, et al. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA. 2002;99:11700\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR136","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nature05349","volume":"444","author":"SG Piccirillo","year":"2006","unstructured":"Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. Bone morpho-genetic proteins inhibit the tumourigenic potential of human brain tumour-initiating cells. Nature. 2006;444:761\u20135.","journal-title":"Nature"},{"key":"155_CR137","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ejca.2006.01.044","volume":"42","author":"AG Schatzlein","year":"2006","unstructured":"Schatzlein AG. Delivering cancer stem cell therapies\u2014a role for nanomedicines? Eur J Cancer. 2006;42:1309\u201315.","journal-title":"Eur J Cancer"},{"key":"155_CR138","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138:645\u201359.","journal-title":"Cell"},{"key":"155_CR139","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcmd.2010.03.008","volume":"45","author":"R Riccioni","year":"2010","unstructured":"Riccioni R, Dupuis ML, Bernabei M, Petrucci E, Pasquini L, Mariani G, et al. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol Dis. 2010;45:86\u201392.","journal-title":"Blood Cells Mol Dis"},{"key":"155_CR140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-4889(01)00175-6","volume":"1542","author":"J Jodoin","year":"2002","unstructured":"Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta. 2002;1542:149\u201359.","journal-title":"Biochim Biophys Acta"},{"key":"155_CR141","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ijc.1283","volume":"92","author":"A Harbottle","year":"2001","unstructured":"Harbottle A, Daly AK, Atherton K, Campbell FC. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance associated protein 1 in acquired doxorubicin resistance. Int J Cancer. 2001;92:777\u201383.","journal-title":"Int J Cancer"},{"key":"155_CR142","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.98106807","volume":"106","author":"SP Verma","year":"1998","unstructured":"Verma SP, Goldin BR, Lin PS. The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids. Environ Health Perspect. 1998;106:807\u201312.","journal-title":"Environ Health Perspect"},{"key":"155_CR143","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.phymed.2008.06.011","volume":"16","author":"F Behnam Rassouli","year":"2009","unstructured":"Behnam Rassouli F, Matin MM, Iranshahi M, Bahrami AR, Neshati V, Mollazadeha S, et al. Mogoltacin enhances vincristine cytotoxicity in human transitional cell carcinoma (TCC) cell line. Phytomedicine. 2009;16:181\u20137.","journal-title":"Phytomedicine"},{"key":"155_CR144","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/znc-2009-5-602","volume":"64","author":"V Neshati","year":"2009","unstructured":"Neshati V, Matin MM, Iranshahi M, Bahrami AR, Behravan J, Mollazadeh S, et al. Cytotoxicity of vincristine on the 5637 cell line is enhanced by combination with conferone. Z Naturforsch C. 2009;64:317\u201322.","journal-title":"Z Naturforsch C"},{"key":"155_CR145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10286020.2010.485565","volume":"12","author":"S Mollazadeh","year":"2010","unstructured":"Mollazadeh S, Matin MM, Iranshahi M, Bahrami AR, Neshati V, Behnam Rassouli F. The enhancement of vincristine cytotoxicity by combination with feselol. J Asian Nat Prod Res. 2010;12:569\u201375.","journal-title":"J Asian Nat Prod Res"},{"key":"155_CR146","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1200\/JCO.2005.01.180","volume":"23","author":"A Cesne Le","year":"2005","unstructured":"Le Cesne A, Blay JY, Judson I, Van Oosterom A, Verweij J, Radford J, et al. Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. J Clin Oncol. 2005;23:576\u201384.","journal-title":"J Clin Oncol"},{"key":"155_CR147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5:219\u201334.","journal-title":"Nat Rev Drug Discov"},{"key":"155_CR148","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","volume":"98","author":"ML Guzman","year":"2001","unstructured":"Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, et al. Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 2001;98:2301\u20137.","journal-title":"Blood"},{"key":"155_CR149","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.leu.2404614","volume":"21","author":"E Griessinger","year":"2007","unstructured":"Griessinger E, Imbert V, Lagadec P, Gonthier N, Dubruil P, Romanelli A, et al. AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells. Leukemia. 2007;21:877\u201385.","journal-title":"Leukemia"},{"key":"155_CR150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1874467211003030098","volume":"3","author":"O Fuchs","year":"2010","unstructured":"Fuchs O. Transcription factor NF-\u03baB inhibitors as a single therapeutic agent or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies. Curr Mol Pharmacol. 2010;3:98\u2013122.","journal-title":"Curr Mol Pharmacol"},{"key":"155_CR151","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-04-3478","volume":"65","author":"KE Miletti-Gonz\u00e1lez","year":"2005","unstructured":"Miletti-Gonz\u00e1lez KE, Chen S, Muthukumaran N, Saglimbeni GN, Wu X, Yang J, et al. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res. 2005;65:6660\u20137.","journal-title":"Cancer Res"},{"key":"155_CR152","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","volume":"12","author":"L Jin","year":"2006","unstructured":"Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006;12:1167\u201374.","journal-title":"Nat Med"},{"key":"155_CR153","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","volume":"100","author":"U Testa","year":"2002","unstructured":"Testa U, Riccioni R, Militi S, Coccia E, Stellacci E, Samoggia P, et al. Elevated expression of IL-3R\u03b1 in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood. 2002;100:2980\u20138.","journal-title":"Blood"},{"key":"155_CR154","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.0902-4441.2003.00184.x","volume":"72","author":"M Graf","year":"2004","unstructured":"Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Eur J Haematol. 2004;72:89\u2013106.","journal-title":"Eur J Haematol"},{"key":"155_CR155","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/sj.leu.2404754","volume":"21","author":"A van Rhenen","year":"2007","unstructured":"van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S, et al. Aberrant marker expression patterns on the CD34+CD38\u2212-stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. Leukemia. 2007;21:1700\u20137.","journal-title":"Leukemia"},{"key":"155_CR156","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","volume":"5","author":"L Jin","year":"2009","unstructured":"Jin L, Lee EM, Ramshaw HS, Busflield SJ, Peoppl AG, Wilkinson L, et al. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor \u03b1 chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell. 2009;5:31\u201342.","journal-title":"Cell Stem Cell"},{"key":"155_CR157","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.cellsig.2007.06.021","volume":"19","author":"E Grinstein","year":"2007","unstructured":"Grinstein E, Wernet P. Cellular signaling in normal and cancerous stem cells. Cell Signal. 2007;19:2428\u201333.","journal-title":"Cell Signal"},{"key":"155_CR158","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1083\/jcb.200211021","volume":"161","author":"P Rajan","year":"2003","unstructured":"Rajan P, Panchision DM, Newell LF, McKay RD. BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol. 2003;161:911\u201321.","journal-title":"J Cell Biol"},{"issue":"1","key":"155_CR159","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","volume":"5","author":"TF Cloughesy","year":"2008","unstructured":"Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, Zhu S, et al. Antitumour activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med. 2008;5(1):e8.","journal-title":"PLoS Med"},{"key":"155_CR160","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.280.5369.1603","volume":"280","author":"MK Cooper","year":"1998","unstructured":"Cooper MK, Porter JA, Young KE, Beachy PA. Teratogen mediated inhibition of target tissue response to Shh signaling. Science. 1998;280:1603\u20137.","journal-title":"Science"},{"key":"155_CR161","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1073733","volume":"297","author":"DM Berman","year":"2002","unstructured":"Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 2002;297:1559\u201361.","journal-title":"Science"},{"key":"155_CR162","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","volume":"66","author":"S Liu","year":"2006","unstructured":"Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006;66:6063\u201371.","journal-title":"Cancer Res"},{"key":"155_CR163","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1073\/pnas.0611682104","volume":"104","author":"CD Peacock","year":"2007","unstructured":"Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J, et al. Hedgehog signaling maintains a tumour stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA. 2007;104:4048\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR164","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1301\/nr.2007.aug.S118-S120","volume":"65","author":"S Byers","year":"2007","unstructured":"Byers S, Shah S. Vitamin D and the regulation of Wnt\/beta-catenin signaling and innate immunity in colorectal cancer. Nutr Rev. 2007;65:S118\u201320.","journal-title":"Nutr Rev"},{"key":"155_CR165","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1158\/0008-5472.CAN-06-3958","volume":"67","author":"M Shih Ie","year":"2007","unstructured":"Shih Ie M, Wang TL. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res. 2007;67:1879\u201382.","journal-title":"Cancer Res"},{"key":"155_CR166","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/0008-5472.CAN-09-1681","volume":"70","author":"H Harrison","year":"2010","unstructured":"Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 2010;70:709\u201318.","journal-title":"Cancer Res"},{"key":"155_CR167","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.molonc.2010.06.005","volume":"4","author":"SP McDermott","year":"2010","unstructured":"McDermott SP, Wicha MS. Targeting breast cancer stem cells. Mol Oncol. 2010;4:404\u201319.","journal-title":"Mol Oncol"},{"key":"155_CR168","first-page":"2783","volume":"24","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24:2783\u2013840.","journal-title":"Anticancer Res"},{"key":"155_CR169","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/mi.6.1.7","volume":"6","author":"DK Das","year":"2006","unstructured":"Das DK, Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv. 2006;6:36\u201347.","journal-title":"Mol Interv"},{"key":"155_CR170","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.bcp.2007.08.001","volume":"74","author":"V Cecchinato","year":"2007","unstructured":"Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A, Sherbet GV, et al. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem Pharmacol. 2007;74:1568\u201374.","journal-title":"Biochem Pharmacol"},{"key":"155_CR171","doi-asserted-by":"crossref","unstructured":"Saito Y, Kitamura H, Hijikata A, Tomizawa-Murasawa M, Tanaka S, Takagi S, et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med. 2010;2:17ra9.","DOI":"10.1126\/scitranslmed.3000349"},{"key":"155_CR172","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1158\/1078-0432.CCR-10-1601","volume":"16","author":"A Dubrovska","year":"2010","unstructured":"Dubrovska A, Elliott J, Salamone RJ, Kim S, Aimone LJ, Walker JR, et al. Combination therapy targeting both tumour-initiating and differentiated cell populations in prostate carcinoma. Clin Cancer Res. 2010;16:5692\u2013702.","journal-title":"Clin Cancer Res"},{"key":"155_CR173","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.1073\/pnas.222491799","volume":"99","author":"Z Qian","year":"2002","unstructured":"Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. Expression profiling of CD34+ haematopoietic stem\/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci USA. 2002;99:14925\u201330.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-011-0155-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-011-0155-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-011-0155-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T13:32:12Z","timestamp":1592314332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-011-0155-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,12]]},"references-count":173,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1007\/s13277-011-0155-8","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,12]]}}}